Together, these findings highlight the importance of both GPC3 and CD147 as clinically relevant antigens in the context of HCC and justify the continued exploration of dual-antigen targeting and logic-gated CAR-NK strategies. This evidence concerns the gene BSG and hepatocellular carcinoma.